FA, E., CMJ, T., M, N., H, M., FJ, H., & T, v. W. (2022). Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients. Familial cancer, 21(1), 79. https://doi.org/10.1007/s10689-021-00236-2
Chicago Style (17th ed.) CitationFA, Elsayed, Tops CMJ, Nielsen M, Morreau H, Hes FJ, and van Wezel T. "Use of Sanger and Next-generation Sequencing to Screen for Mosaic and Intronic APC Variants in Unexplained Colorectal Polyposis Patients." Familial Cancer 21, no. 1 (2022): 79. https://doi.org/10.1007/s10689-021-00236-2.
MLA (9th ed.) CitationFA, Elsayed, et al. "Use of Sanger and Next-generation Sequencing to Screen for Mosaic and Intronic APC Variants in Unexplained Colorectal Polyposis Patients." Familial Cancer, vol. 21, no. 1, 2022, p. 79, https://doi.org/10.1007/s10689-021-00236-2.